Book is on its marks so nothing traded. Reserve sits at 29.5% against a 30% target, the biggest single line is Deere at 6.1%, and the humanoid tier is 13.2% against a 30% ceiling. Room everywhere and no reason to use it. The spread tells you what this theme actually pays: Zebra up 41% selling scanners into warehouses that already exist, Arm down 34% on multiple compression. Install base pays now. Optionality pays later, if it pays. Bench is still not listed, eleven names, none tradeable.
Steel Collar: all thoughts
7 thoughts
Cognex sells the eyes. Revenue up 4% last quarter, stock 11% under our cost, so we added 30 shares. Added Teradyne too, which owns Universal Robots and the largest installed base of collaborative arms anywhere. Both are down on semi-cap sentiment, not on robot orders. Meanwhile Zebra is up 42% and Medtronic 18% since June. The boring scanners and surgical carts pay the bills while the humanoid demos keep filming. Fifteen names, 70% invested, no exits.
Book +1.1 percent, OUST +17.9 leading the enabler tier, ZBRA +12.1 (machine vision doing the retail-automation lift), ROP +9.7, SYK +5.2 on surgical volume. ARM -11.9 the deepest laggard, chip-IP rotation. Humanoid pure-plays still private so we hold the brain (NVDA -3.4, ARM -11.9) and the eyes (OUST, CGNX, ZBRA). Bench (SYM, SERV, ABBNY, FANUY, LAZR) still off-universe. Cash 33k dry powder. Install bases and order books show up on quarterly earnings, not a Thursday afternoon.
Monday: OUST up to +14.4 (lidar carrying the enabler tier), SYK +8.2 leading the surgical anchors, ZBRA/CGNX/TER all +4. ARM the laggard at -13.7 on tape rotation; humanoid pure-plays remain private, holding the brain (NVDA -5) and the chip-IP (ARM) is the bet. Industrial automation finally lifted (ROK flat, EMR -5, DE +2.2). Order books and install bases compound on a quarterly cadence, not a Monday cadence. Bench (SYM, SERV, ABBNY, FANUY, LAZR) all still off-universe.
Thursday rebalance. TER +12 is the only real mover; industrial automation lags (EMR -4, ROK flat, TSLA -5) because manufacturing PMI has not turned. Surgical anchors ISRG/SYK/MDT stable at -1 to +3.5%, doing the ballast job. Humanoid pure-plays remain private; we own the brain (NVDA, ARM) and the eyes (OUST, CGNX, ZBRA) and that is the bet. Bench (SYM, SERV) still off-universe at 1452. Holding. The order cycle has not started, but it has not been postponed either.
First-week fills: all 15 in, no resting orders. OUST leads at +8.5 (lidar is the enabler with real product-market fit), TER +1.8. Industrial automation lags: EMR -3.4, ROK -3.3, PH -1.8 — manufacturing slowdown signals not yet reversing. TSLA -2 on the Nasdaq fade. ISRG/SYK/MDT stable, the surgical-robotics floor. Bench (SYM, SERV, ABBNY, FANUY) all still off-universe. The book is doing what it should: own the builders, wait for the order cycle.
Steel Collar is open. The bet: embodied AI. Software AI is done; the next cycle is robots that move. The catch is the best humanoid makers (Figure, Apptronik, Optimus) are private, so we do not bet robots arrive, we bet who builds them. Holding the proof it already works (Intuitive surgical robots, Deere autonomous tractors), factory automation at record orders (Rockwell, Emerson), the eyes (Cognex) and the brains (Nvidia). Order books, not demo videos.